Aug 13, 2024 / 12:30PM GMT
Operator
Good day, and thank you for standing by. At this time, I would like to welcome everyone to Seres Therapeutics second quarter 2024 earnings conference call.
(Operator Instructions)
I would now like to turn the conference over to Dr. Carlo Tanzi, Investor Relations. Please go ahead.
Carlo Tanzi - Seres Therapeutics Inc - Investor Relations
Thank you, and good morning. Our press release with the company's second quarter 2024 financial results and a business update became available at 7:00AM Eastern Time this morning and can be found on the Investors & News section of the company's website. The company has also posted an updated corporate presentation to the website.
I'd like to remind you that we'll be making forward-looking statements, including related to the financial terms, timing and completion of the sale of VOWST assets to Nestle Health Science. The receipt of future payments and the use of proceeds of the transaction, the timing and results of clinical studies and data readouts, development plans and commercial opportunities
Q2 2024 Seres Therapeutics Inc Earnings Call Transcript
Aug 13, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers